Mabion S.A. | Balance Sheet

Fiscal year is January-December. All values PLN Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,605.80
6,953.00
6,074.00
14,826.00
1,038.00
58,418
Total Accounts Receivable
6,611.20
2,458.00
2,918.00
3,223.00
1,511.00
2,536
Inventories
1,072.30
4,563.00
1,278.00
4,840.00
7,297.00
10,368
Other Current Assets
492.20
812.00
282.00
141.00
129.00
840
Total Current Assets
11,781.40
14,786.00
10,552.00
23,030.00
9,975.00
72,162
Net Property, Plant & Equipment
19,053.70
63,259.00
73,387.00
68,107.00
72,276.00
72,445
Long-Term Note Receivable
110.10
-
110.00
110.00
194.00
110
Other Assets
44,437.70
69,988.00
-
-
-
-
Total Assets
75,468.10
148,116.00
84,049.00
91,247.00
82,445.00
144,717
ST Debt & Current Portion LT Debt
-
32.00
77.00
12,672.00
61,865.00
Accounts Payable
1,426.50
4,469.00
11,880.00
9,915.00
14,005.00
Other Current Liabilities
2,680.70
3,727.00
10,485.00
50,871.00
44,500.00
Total Current Liabilities
4,107.20
8,228.00
22,442.00
73,458.00
120,370.00
Long-Term Debt
-
64.00
155.00
48.00
4,166.00
Provision for Risks & Charges
8.10
21.00
-
-
-
Deferred Taxes
80.10
75.00
-
-
-
Other Liabilities
19,292.80
40,011.00
15,997.00
14,012.00
12,067.00
Total Liabilities
23,413.00
48,332.00
38,594.00
87,518.00
136,603.00
Common Equity (Total)
52,055.10
99,784.00
45,455.00
3,729.00
54,158.00
Total Shareholders' Equity
52,055.10
99,784.00
45,455.00
3,729.00
54,158.00
Total Equity
52,055.10
99,784.00
45,455.00
3,729.00
54,158.00
Liabilities & Shareholders' Equity
75,468.10
148,116.00
84,049.00
91,247.00
82,445.00

About Mabion

View Profile
Address
ul. gen. Mariana Langiewicza 60
Konstantynów Lódzki LD 95
Poland
Employees -
Website http://www.mabion.eu
Updated 07/08/2019
Mabion SA is a biotechnology company, which engages in the development and manufacturing of biotech drugs. Its products, which are based on humanized monoclonal antibodies, are used for the treatment of cancer and metabolic diseases. It also involved research in the field of biotechnology.